Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 21, Issue 10, Pages 2599-2609
Publisher
Wiley
Online
2017-06-30
DOI
10.1111/jcmm.13180
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Glucose Impairs Insulin Signaling in the Glomerulus: An In Vitro and Ex Vivo Approach
- (2016) Elias N. Katsoulieris et al. PLoS One
- PTEN Inhibits High Glucose-Induced Phenotypic Transition in Podocytes
- (2015) Lingling Xing et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The PI3K/p-Akt signaling pathway participates in calcitriol ameliorating podocyte injury in DN rats
- (2014) Zhixia Song et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats
- (2014) Xiaoliang Zhang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Glucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms’ tumor 1 (WT1)
- (2013) Nikolaos E Tsotakos et al. BMC CELL BIOLOGY
- Vitamin D Receptor Activators Upregulate and Rescue Podocalyxin Expression in High Glucose-Treated Human Podocytes
- (2013) S.N. Verouti et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
- (2012) X. Luo et al. GENES & DEVELOPMENT
- Identification of the vitamin D receptor in various cells of the mouse kidney
- (2012) Yongji Wang et al. KIDNEY INTERNATIONAL
- A new regulator of podocytes
- (2012) Susan J. Allison Nature Reviews Nephrology
- Cardiovascular risk in diabetic end-stage renal disease patients
- (2011) Angela Yee-Moon WANG Journal of Diabetes
- Blockade of Wnt/ -Catenin Signaling by Paricalcitol Ameliorates Proteinuria and Kidney Injury
- (2010) W. He et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
- (2010) Dick de Zeeuw et al. LANCET
- 1,25-Dihydroxyvitamin D3 Prevents Puromycin Aminonucleoside-Induced Apoptosis of Glomerular Podocytes by Activating the Phosphatidylinositol 3-Kinase/Akt-Signaling Pathway
- (2009) Houqin Xiao et al. AMERICAN JOURNAL OF NEPHROLOGY
- Renoprotective effects of vitamin D analogs
- (2009) Yan Chun Li KIDNEY INTERNATIONAL
- Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats
- (2009) I. Matsui et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor
- (2009) Maro Okamura et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- PODOCYTE INJURY IS SUPPRESSED BY 1,25-DIHYDROXYVITAMIN D3VIA MODULATION OF TRANSFORMING GROWTH FACTOR-β1/BONE MORPHOGENETIC PROTEIN-7 SIGNALLING IN PUROMYCIN AMINONUCLEOSIDE NEPHROPATHY RATS
- (2008) Hou-Qin Xiao et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
- (2008) Z. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The pathogenesis of diabetic nephropathy
- (2008) Suma Dronavalli et al. Nature clinical practice. Endocrinology & metabolism
- Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes
- (2007) J. Zhu et al. KIDNEY INTERNATIONAL
- Renoprotective role of the vitamin D receptor in diabetic nephropathy
- (2007) Z. Zhang et al. KIDNEY INTERNATIONAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started